BrainSight AI raises $5M led by IAN Alpha Fund for neuroimaging AI psychiatric diagnosis platform
Summary
Bangalore-based BrainSight AI raised $5 million led by IAN Alpha Fund (Indian Angel Network) to scale their deep learning platform for brain imaging analysis applied to psychiatric disorder diagnosis. The platform uses structural and functional MRI analysis to provide objective clinical decision support for depression, schizophrenia, and bipolar disorder — conditions where neuroimaging biomarkers are increasingly recognized as clinically relevant. India's severe shortage of psychiatrists (fewer than 0.3 per 100,000 population) creates a compelling product-market fit for AI-assisted psychiatric neuroimaging.
Why it matters
BrainSight AI represents the India-for-India neurotech thesis applied to psychiatric neuroimaging. India has 150 million people with treatable mental health conditions and fewer than 4,000 psychiatrists nationwide — AI neuroimaging decision support tools that help primary care physicians and general practitioners make better referral and treatment decisions could reach millions of patients that specialist-dependent diagnostic workflows never will.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial